Walleye Trading
PDLI

Walleye Trading’s PDL BioPharma, Inc. PDLI Stock Holding History

Walleye Trading’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-127,000
Closed -$431K – 4879
2017
Q3 		$431K Buy
+127,000
New +$353K ﹤0.01% 2607
2017
Q2 		– Sell
-16,800
Closed -$38K – 5379
2017
Q1 		$38K Buy
16,800
+14,500
+630% +$32.1K ﹤0.01% 3908
2016
Q4 		$5K Buy
+2,300
New +$6.42K ﹤0.01% 4475
2015
Q4 		– Sell
-200
Closed -$1K – 6212
2015
Q3 		$1K Buy
+200
New +$1.15K ﹤0.01% 4878

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Walleye Trading's PDLI Position: Q4 2017 in Review

Walleye Trading sold out of PDL BioPharma, Inc. (PDLI) in Q4 2017, closing a stake of 127,000 shares — an estimated $431K sold.

Walleye Trading first reported a position in PDLI in Q3 2015 and held it in 4 quarters. The position peaked at $431K in Q3 2017. 187 funds tracked by Wall St. Rank hold PDLI as of Q4 2017.

  • Walleye Trading reported no remaining PDL BioPharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Walleye Trading sold 127,000 PDL BioPharma, Inc. shares in Q4 2017, an estimated $431K.
  • Walleye Trading first reported a position in PDL BioPharma, Inc. in Q3 2015 and held it in 4 quarters.
  • Walleye Trading's PDL BioPharma, Inc. position peaked at $431K in Q3 2017.
  • 187 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2017.

Based on Walleye Trading's 13F filing for Q4 2017, filed 14 Feb 2018.